Joel Michael Maryles - Mar 7, 2022 Form 4 Insider Report for Chemomab Therapeutics Ltd. (CMMB)

Role: Director
Signature: /s/ Matthew Rudolph, Esq., Attorney-in-Fact for Joel Michael Maryles
Stock symbol: CMMB
Transactions as of: Mar 7, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/9/2022, 03:01 PM
Next filing: Mar 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMMB	Option to Purchase American Depositary Shares	Award	$0	+6.82K		$0.00	6.82K	Mar 7, 2022	American Depositary Shares	6.82K	$3.53	Direct	F1, F2
transaction	CMMB	Option to Purchase American Depositary Shares	Award	$0	+11.9K		$0.00	11.9K	Apr 19, 2021	American Depositary Shares	11.9K	$27.26	Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options vest and become exercisable in their entirety on March 16, 2023.
F2	Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F3	No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F4	These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.